JNJ-18038683

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameJNJ-18038683
Drug Alias NameJNJ-18038683
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonistsSerotonin 7 (5-HT7) receptor antagonists
TargetsSerotonin 7 (5-HT7) receptorSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsDepressive Disorder, MajorBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsBipolar Disorder
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A